The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.
Recommended - Firms: transactions
Gold - Firms: litigation
Setting the standard of excellence in Spain for the past four decades, Clifford Chance is “the go-to for multinational patent-holding companies, particularly in the pharmaceutical sector”. “The leading pharmaceutical patent litigator” Miquel Montañá heads up the IP group and dispenses exceptional leadership to a team stacked with talent. He has recently represented Novartis in a high-profile patent infringement proceeding against several companies involving enforcement of a patent that had not yet been granted. Montañá handled this alongside IAM Patent 1000 debutant Adrián Crespo Velasco, who has an extremely quick and strategic mind that can think through the most complex legal questions. Co-head of the tech group Josep Montefusco can be found masterminding particularly complex contentious matters and has recently advised leading US medical device company Edwards Lifesciences in patent infringement proceedings involving four asserted patents.
Bronze - Firms: infringement
Recommended - Firms: transactions
The comprehensive IP offering at the German branch of multinational firm Clifford Chance has recently received a significant boost with the recent acquisition of Stefan Richter and Tobias Hessel from Hoyng Rokh Monegier. Peers rate both litigators as among the country’s very best, with “deep industry expertise”. The two worked side by side at their old practice for Huawei in the Good Kaisha IP Bridge case, and played a supporting role for Deutsche Telekom in a very prominent SEP/FRAND matter against Intellectual Ventures. Smart, strategic and experienced, the pair are a significant addition to the Clifford Chance team. Claudia Milbradt heads up the firm’s offering, and is a tech specialist. One important feature of the practice is its deep expertise in transactional work, from collaboration agreements to tech transfers and M&A due diligence. Milbradt’s expertise in these fields ensures her advice is always commercially salient, while her enforcement experience allows her to view deals with an eye to future litigation. Florian Reiling is a non-contentious specialist. He is especially well equipped to render contractual advice in pharmaceutical and healthcare-related multinational projects and transactions. However, he also brings his commercially astute counsel to a range of other industries.
Jurisdiction